|
Sign In to gain access to subscriptions and/or personal tools.
|
Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro
N Del Papa
E Raschi
Department of Internal Medicine; Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy
G Moroni
Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy
P Panzeri
M O Borghi
Department of Internal Medicine; Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy
C Ponticelli
Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy
A Tincani
G Balestrieri
Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy
P L Meroni
Department of Internal Medicine; Division of Nephrology and Dialysis-IRCCS Policlinico, University of Milan and Servizio di Immunologia Clinica, Spedali Civili, Brescia, Italy
Affinity purified immunoglobulin G (IgG) fractions from systemic lupus erythematosus (SLE) patients positive for anti-endothelial cell antibodies (AECA) bind human umbilical vein endothelial cell (HUVEC) monolayers. In vitro incubation of serial protein concentrations of SLE AECA IgG induces a dose-dependent endothelial activation: i) increase of functional adhesion of the monocytic cell line U937; ii) upregulation of E-Selectin, ICAM-1, VCAM-1 expression evaluated by a cell solid-phase enzyme linked immunoassay; and iii) increased secretion of interleukin (IL)-6 in the culture supernatants. Control experiments carried out with HUVEC monolayers incubated with IgG fractions from normal healthy controls or from AECA negative SLE sera do not affect at all endothelial adhesion molecule expression or pro-inflammatory cytokine secretion. The AECA IgG effects are not related to both anti-phospholipid or anti-DNA activities.
Taken together the findings suggest that these autoantibodies might be important in recruiting and in activating mononuclear leukocytes responsible for vessel wall infiltration and raise the possibility that AECA might display a pathogenic role in SLE vessel damage.
Key Words: systemic lupus erythematosus anti-endothelial cell antibodies adhesion molecules cytokines
Lupus, Vol. 8, No. 6,
423-429 (1999)
DOI: 10.1177/096120339900800603

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Domiciano, J. Carvalho, and Y. Shoenfeld
Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases
Lupus,
November 1, 2009;
18(13):
1233 - 1238.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Montecucco and F. Mach
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis
Rheumatology,
January 1, 2009;
48(1):
11 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jiang, J.-j. Zhang, J.-c. Lv, G. Liu, W.-z. Zou, M.-h. Zhao, and H. Zhang
Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions
Nephrol. Dial. Transplant.,
December 1, 2008;
23(12):
3921 - 3927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Gautier, T. Huby, B. Ouzilleau, C. Doucet, F. Saint-Charles, G. Gremy, M. J. Chapman, and P. Lesnik
Enhanced Immune System Activation and Arterial Inflammation Accelerates Atherosclerosis in Lupus-Prone Mice
Arterioscler Thromb Vasc Biol,
July 1, 2007;
27(7):
1625 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. J. Florey, M. Johns, O. O. Esho, J. C. Mason, and D. O. Haskard
Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2
Blood,
May 1, 2007;
109(9):
3881 - 3889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Belizna, A Duijvestijn, M Hamidou, and J W Cohen Tervaert
Antiendothelial cell antibodies in vasculitis and connective tissue disease
Ann Rheum Dis,
December 1, 2006;
65(12):
1545 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G R V Hughes and H Phillips
Mycophenolate mofetil and cardiovascular disease
Lupus,
November 1, 2006;
15(11_suppl):
1 - 2.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S I van Leuven, J J. Kastelein, D P D'Cruz, G R Hughes, and E S Stroes
Atherogenesis in rheumatology
Lupus,
March 1, 2006;
15(3):
117 - 121.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Hall and N. Dalbeth
Disease modification and cardiovascular risk reduction: two sides of the same coin?
Rheumatology,
December 1, 2005;
44(12):
1473 - 1482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Williams, R. Colman, C. J. Brookes, C. O. Savage, and L. Harper
Anti-endothelial cell antibodies from lupus patients bind to apoptotic endothelial cells promoting macrophage phagocytosis but do not induce apoptosis
Rheumatology,
July 1, 2005;
44(7):
879 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-F. Lin, S.-C. Chiu, Y.-L. Hsiao, S.-W. Wan, H.-Y. Lei, A.-L. Shiau, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, et al.
Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1
J. Immunol.,
January 1, 2005;
174(1):
395 - 403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rajagopalan, E. C. Somers, R. D. Brook, C. Kehrer, D. Pfenninger, E. Lewis, A. Chakrabarti, B. C. Richardson, E. Shelden, W. J. McCune, et al.
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
Blood,
May 15, 2004;
103(10):
3677 - 3683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N J Abbott, L L. Mendonca, and D E. Dolman
The blood-brain barrier in systemic lupus erythematosus
Lupus,
December 1, 2003;
12(12):
908 - 915.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J E Salmon, G Girardi, and V M Holers
Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis
Ann Rheum Dis,
November 1, 2002;
61(90002):
ii46 - 50.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Segal, A. Bihorac, and M. Koc
Circulating endothelial cells: tea leaves for renal disease
Am J Physiol Renal Physiol,
July 1, 2002;
283(1):
F11 - F19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Holers, G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando, et al.
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
J. Exp. Med.,
January 22, 2002;
195(2):
211 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A S Wierzbicki
Lipid-lowering drugs in lupus: an unexplored therapeutic intervention
Lupus,
March 1, 2001;
10(3):
233 - 236.
[Abstract]
[PDF]
|
 |
|
|
|